Hill-rom Holdings Stock News

The global Home Healthcare market is expected to reach US$ 302.5 Billion by 2027, with a CAGR of 10.2% from 2021 to 2027. Rapid growth in the elderly population and the rising incidence of chronic diseases, as well as the

Wearable Patch Market Report 2021 added recently by CMI, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application

Zacks Industry Outlook Highlights: Abbott Lab, Bio-Rad Lab and Hill-Rom Holdings

Global Incentive spirometer Sales Market Report 2021 The Incentive spirometer Market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the

Despite the COVID-19 pandemic induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ABT, BIO and HRC are well-p

The Patient Handling Equipment Market Report provides detailed analysis of Growth Factors of the market as well as it gives an analysis of the Market size, Latest trends, SWOT Analysis by Regions and Forecasted market research data until 2027. The Patient

Despite the COVID-19 pandemic induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ABT, BIO and HRC are well-p

Hill-Rom Holdings, Inc. (NYSE:HRC) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 6,570,000 shares, a growth of 23.0% from the October 31st total of 5,340,000 shares. Based on an average daily trading volume, of 1,180,000 shares, the days-to-cover ratio is presently 5.6 []

The global Patient Positioning System market was valued at 899.86 Million USD in 2020 and will grow with a CAGR of 2.55% from 2021 to 2027. The rise in the region''s elderly population, the ever-increasing competitive environment, and technological improvement

Hill-Rom Holdings Inc (HRC) shares closed today at 0.5% below its 52 week high of $156.22, giving the company a market cap of $10B. The stock is currently up 59.7% year-to-date, up 63.9% over the past 12 months, and up 197.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 34.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1922.4% The company's stock price performance over the past 12 months beats the peer average by -3704.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -212.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Investors are optimistic about Hill-Rom (HRC) on strong fiscal fourth-quarter results and progress in digital health.

Investors are optimistic about Hill-Rom (HRC) on strong fiscal fourth-quarter results and progress in digital health.

Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) have been given an average recommendation of Hold by the six ratings firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year price target among analysts []

State of Alaska Department of Revenue lessened its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 39.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,102 shares of the medical technology companys stock after selling 6,452 shares during the quarter. State []

CHICAGO TRUST Co NA bought a new position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,435 shares of the medical technology company’s stock, valued at approximately $215,000. Other institutional investors also recently […]